Guided Therapeutics, Inc. (GTHP)
OTCMKTS
· Delayed Price · Currency is USD
0.1250
+0.0350 (38.89%)
May 16, 2025, 3:08 PM EDT
Guided Therapeutics Revenue
Guided Therapeutics had revenue of $1,000.00 in the twelve months ending March 31, 2025, down -98.78% year-over-year. In the year 2024, Guided Therapeutics had annual revenue of $7.00K, down -92.86%.
Revenue (ttm)
1,000.00
Revenue Growth
-98.78%
P/S Ratio
9,863.77
Revenue / Employee
250.00
Employees
4
Market Cap
9.86M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.00K | -91.00K | -92.86% |
Dec 31, 2023 | 98.00K | 85.00K | 653.85% |
Dec 31, 2022 | 13.00K | -68.00K | -83.95% |
Dec 31, 2021 | 81.00K | -21.00K | -20.59% |
Dec 31, 2020 | 102.00K | 66.00K | 183.33% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
BioStem Technologies | 332.45M |
Guided Therapeutics News
- 5 months ago - Guided Therapeutics Receives Order and Full Payment From Indonesia for 4 LuViva Systems and 1,200 Disposables - Business Wire
- 11 months ago - Guided Therapeutics' Announces Data from Chinese NMPA Clinical Study Signed Off by All Four Clinical Sites With Better Than Expected Results - Business Wire
- 1 year ago - Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results - Business Wire
- 1 year ago - Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval - Business Wire